A detailed history of Verition Fund Management LLC transactions in Biote Corp. stock. As of the latest transaction made, Verition Fund Management LLC holds 10,860 shares of BTMD stock, worth $46,372. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,860
Previous 26,115 58.41%
Holding current value
$46,372
Previous $145,000 53.79%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$5.04 - $6.93 $76,885 - $105,717
-15,255 Reduced 58.41%
10,860 $67,000
Q3 2024

Nov 14, 2024

SELL
$5.33 - $8.36 $77,343 - $121,311
-14,511 Reduced 35.72%
26,115 $145,000
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $221,005 - $303,476
40,626 New
40,626 $303,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $32.3M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.